BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19696031)

  • 1. Expression of neurotrophic factors in diabetic muscle--relation to neuropathy and muscle strength.
    Andreassen CS; Jakobsen J; Flyvbjerg A; Andersen H
    Brain; 2009 Oct; 132(Pt 10):2724-33. PubMed ID: 19696031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered mobility of large joints in association with neuropathy in patients with long-standing insulin-dependent diabetes mellitus.
    Andersen H; Mogensen PH
    Diabet Med; 1997 Mar; 14(3):221-7. PubMed ID: 9088771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats.
    Fernyhough P; Diemel LT; Tomlinson DR
    Diabetologia; 1998 Mar; 41(3):300-6. PubMed ID: 9541170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striated muscle fiber size, composition, and capillary density in diabetes in relation to neuropathy and muscle strength.
    Andreassen CS; Jensen JM; Jakobsen J; Ulhøj BP; Andersen H
    J Diabetes; 2014 Sep; 6(5):462-71. PubMed ID: 24397623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy.
    Andersen H; Borre M; Jakobsen J; Andersen PH; Vilstrup H
    Hepatology; 1998 May; 27(5):1200-6. PubMed ID: 9581671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxides in type 2 diabetic patients with neuropathy.
    Migdalis IN; Triantafilou P; Petridou E; Varvarigos N; Totolos V; Rigopoulos A
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():5-12. PubMed ID: 18426075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
    Kamiya H; Murakawa Y; Zhang W; Sima AA
    Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor mRNA levels are up-regulated in hindlimb skeletal muscle of diabetic rats: effect of denervation.
    Fernyhough P; Maeda K; Tomlinson DR
    Exp Neurol; 1996 Oct; 141(2):297-303. PubMed ID: 8812163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.
    Baum P; Hermann W; Verlohren HJ; Wagner A; Lohmann T; Grahmann F
    J Neurol; 2003 Jun; 250(6):682-7. PubMed ID: 12796829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia inhibitory factor and neurotrophins support overlapping populations of rat nodose sensory neurons in culture.
    Thaler CD; Suhr L; Ip N; Katz DM
    Dev Biol; 1994 Feb; 161(2):338-44. PubMed ID: 8313987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF gene transfer for diabetic neuropathy.
    Isner JM; Ropper A; Hirst K
    Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.
    Ohi T; Saita K; Furukawa S; Ohta M; Hayashi K; Matsukura S
    Exp Neurol; 1998 Jun; 151(2):215-20. PubMed ID: 9628756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome.
    Dornonville de la Cour C; Andersen H; Stålberg E; Fuglsang-Frederiksen A; Jakobsen J
    Muscle Nerve; 2005 Jan; 31(1):70-7. PubMed ID: 15543551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
    Harbo T; Andersen H; Overgaard K; Jakobsen J
    J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of diabetic neuropathy: a neurophysiological study on 100 patients.
    Braune HJ
    Electromyogr Clin Neurophysiol; 1997 Oct; 37(7):399-407. PubMed ID: 9402428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical diabetic neuropathy: a common complication in Saudi diabetics.
    Akbar DH; Mira SA; Zawawi TH; Malibary HM
    Saudi Med J; 2000 May; 21(5):433-7. PubMed ID: 11500676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus.
    Sandhu HS; Butt AN; Powrie J; Swaminathan R
    Ann N Y Acad Sci; 2008 Aug; 1137():258-63. PubMed ID: 18837957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications.
    Andersen H; Poulsen PL; Mogensen CE; Jakobsen J
    Diabetes; 1996 Apr; 45(4):440-5. PubMed ID: 8603765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.